BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 38604406)

  • 21. Characteristics and causes of pre-donation deferrals at a Chinese blood center.
    Yang Y
    Transfus Apher Sci; 2021 Aug; 60(4):103153. PubMed ID: 34016553
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of reasons of blood donor deferral at a tertiary care institute in India and its reflections on community health status.
    Malhotra S; Negi G
    Asian J Transfus Sci; 2023; 17(1):48-52. PubMed ID: 37188024
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Whole blood donor behavior and availability after deferral: Consequences of a new ferritin monitoring policy.
    Spekman MLC; Ramondt S; Sweegers MG
    Transfusion; 2021 Apr; 61(4):1112-1121. PubMed ID: 33368385
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessment of motivations for return donation among deferred blood donors. American Red Cross ARCNET Study Group.
    Munsterman KA; Grindon AJ; Sullivan MT; Trouern-Trend J; Blackmon MJ; Watkins J; Williams AE
    Transfusion; 1998 Jan; 38(1):45-50. PubMed ID: 9482393
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stigmatizing deferrals disproportionally reduce donor return rates: Evidence from Brazil.
    Vieites Y; Ferreira CM; Goldszmidt R; Andrade EB
    Vox Sang; 2024 Jun; 119(6):606-611. PubMed ID: 38425028
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plateletpheresis donor deferral patterns at a tertiary care hospital in North India: A need for rethink of haemoglobin cutoff.
    Sharma H; Khajuria K; Bansal N; Thakur K; Sharma A
    Transfus Clin Biol; 2023 May; 30(2):268-271. PubMed ID: 36893913
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Notifying donors when their deferral is ending: An effective donor retention strategy.
    Gemelli CN; Thijsen A; Van Dyke N; Kruse SP; Davison TE
    Transfusion; 2021 Oct; 61(10):2930-2940. PubMed ID: 34352927
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Whole blood donor deferral rate and characteristics of the Turkish population.
    Arslan O
    Transfus Med; 2007 Oct; 17(5):379-83. PubMed ID: 17725552
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effectiveness of iron education through a mobile application on donor return after deferral for low hemoglobin.
    Hasan MI; Noordin SS; Hami R; Ishak N; Achuthan A
    Blood Transfus; 2022 Nov; 20(6):446-453. PubMed ID: 35848625
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The risks of low hemoglobin deferral in a large retrospective cohort of plasmapheresis donors and the influence factors of return for a subsequent donation in China.
    Xiao G; Dong D; Wang Y; Li C; Huang GT; Yang H; Huang J; Chen F
    PeerJ; 2023; 11():e14999. PubMed ID: 36935911
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Changes in the Whole Blood Donor Population in South-West Germany: 2010 versus 2016.
    Müller-Steinhardt M; Weidmann C; Klüter H
    Transfus Med Hemother; 2017 Aug; 44(4):217-223. PubMed ID: 28924426
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The impact of donor selection on blood safety in Iran.
    Razjou F; Maghsudlu M; Nasizadeh S; Zadsar M
    Transfus Apher Sci; 2012 Aug; 47(1):13-6. PubMed ID: 22521567
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Educating donors about deferrals through the provision of tailored materials: Findings from a survey of deferred donors.
    Gemelli CN; Kruse SP; Thijsen A; Van Dyke N; Davison TE
    Transfusion; 2021 Mar; 61(3):822-829. PubMed ID: 33615506
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Blood donor selection and deferral pattern as an important tool for blood safety in a tertiary care hospital.
    Shrivastava M; Shah N; Navaid S; Agarwal K; Sharma G
    Asian J Transfus Sci; 2016; 10(2):122-6. PubMed ID: 27605848
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Temporary deferral and donor return.
    Piliavin JA
    Transfusion; 1987; 27(2):199-200. PubMed ID: 3824481
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rates and reasons for blood donor deferral, Shiraz, Iran. A retrospective study.
    Kasraian L; Negarestani N
    Sao Paulo Med J; 2015 Feb; 133(1):36-42. PubMed ID: 25166463
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Review of blood donor deferral with emphasis on donor and patient safety.
    Lamba DS; Sachdev S; Hans R; Krishan Dhawan H; Sharma RR; Marwaha N
    Transfus Clin Biol; 2023 Feb; 30(1):56-62. PubMed ID: 35835317
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Retrospective Analysis of Apheresis Donor Deferral and Adverse Reactions at a Tertiary Care Centre in India.
    Arora D; Garg K; Kaushik A; Sharma R; Rawat DS; Mandal AK
    J Clin Diagn Res; 2016 Nov; 10(11):EC22-EC24. PubMed ID: 28050376
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New tatt? We're ok with that! Relaxing the tattoo deferral for plasmapheresis donors maintains safety and increases donations.
    Styles CE; Hoad VC; Harley R; Kaldor J; Gosbell IB
    Vox Sang; 2024 Jun; ():. PubMed ID: 38925639
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Blood donation behaviour and attitudes towards the 12-month deferral policy among gay and bisexual men in New Zealand.
    Sriamporn KT; Saxton P; Consedine N; Hammoud M; Prestage G
    Vox Sang; 2022 Oct; 117(10):1145-1152. PubMed ID: 35919939
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.